Press Release: Sanofi appoints Paulo Fontoura as Global Head of R&D

Sanofi swaps R&D leaders; Merck’s Prometheus deal pays dividends

Houman Ashrafian is leaving Sanofi to pursue a new opportunity. Elsewhere, one of Merck’s prized immune drugs succeeded in a pivotal study and a psychedelics biotech’s shares surged.

Sanofi names ex-Roche exec Fontoura as R&D chief

Paulo Fontoura, currently chief medical officer of Xaira Therapeutics, will replace Houman Ashrafian as Sanofi's R&D head on 1st September.

Sanofi names new R&D head as it tries to jump-start pipeline

The move to appoint a new R&D head comes as Sanofi faces pressure to develop more blockbusters, with Dupixent's exclusivity loss looming.

Press Release: Sanofi appoints Paulo Fontoura as Global Head of R&D

Sanofi appoints Paulo Fontoura as Global Head of R&D Paris, June 22, 2026. Sanofi today announced the appointment of

Sanofi Names Former Xaira and Roche Executive Paulo Fontoura as Global Head of R&D Pharma

Open the article to view the coverage from EuropaWire.eu

Sanofi R&D leader Houman Ashrafian to depart, Paulo Fontoura to take the reins

Less than two months after Belén Garijo took over as Sanofi’s CEO, the drugmaker has found itself a new R&D chief. Paulo Fontoura will take up the role of global head of ...